Drugs / G-Pump
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02081001 | Mar → Aug 2014 | hypoglycemia | Xeris Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-Pump | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02081001 ↗ |
| Known as | glucagon | “The purpose of the study is to assess the safety, speed of absorption, and onset of action of G-Pump™ (glucagon infusion) at three subcutaneous doses as compared to Novo...” NCT02081001 ↗ |